SCHEMBL7854147

SCHEMBL7854147

CC(=O)COCC(=O)Nc1ccn[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.57
FFAR2 O15552 1/20 0.41
CHRNB2 P17787 1/20 0.38
CHRNA4 P43681 1/20 0.38
EGFR P00533 1/20 0.38
HPGDS O60760 1/20 0.38
CTSK P43235 2/20 0.37
KIT P10721 1/20 0.36
PDGFRA P16234 1/20 0.36
KDR P35968 1/20 0.36
MTOR P42345 3/20 0.36
PIK3CA P42336 2/20 0.36
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35
ALOX15 P16050 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5306352 0.86 PKM (0.55) PKMFFAR2CHRNB2CHRNA4EGFR
SCHEMBL12974928 0.84 PKM (0.53) PKMFFAR2CHRNB2CHRNA4EGFR
SCHEMBL2661353 0.77 PKM (0.67) PKMFFAR2CHRNB2CHRNA4EGFR
SCHEMBL3451050 0.75
SCHEMBL4561823 0.74 PKM (0.63) PKMFFAR2EGFRMTORPIK3CA
SCHEMBL4383929 0.74 PKM (0.58) PKMFFAR2CHRNB2CHRNA4EGFR
SCHEMBL14081443 0.70 PKM (0.46) PKMFFAR2EGFRMTORPIK3CA
SCHEMBL1012929 0.69
SCHEMBL13373451 0.68 PKM (0.51) PKMFFAR2EGFRHPGDSKIT
SCHEMBL16404380 0.68 POLB (0.61) NPC1POLBRAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010127272-A2 HYDROXYETHYLAMINO SULFONAMIDE DERIVATIVES CONCERT PHARMACEUTICALS, INC. (US) 2010-11-04 WO disclosed
WO-2006104646-A1 HIV PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2006-10-05 WO disclosed